Diania Robinson

Diania Robinson serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from market research and solicitation development to contract award and administration. She plays a critical role in ensuring compliance with the Federal Acquisition Regulation (FAR) while advancing mission-critical procurement objectives. Her portfolio primarily encompasses complex procurements in pharmaceuticals, medical devices, and analytical instrumentation, requiring deep technical understanding and precise contract structuring. She routinely handles both competitive and non-competitive acquisitions, leveraging best practices in source selection and performance-based contracting to deliver high-value outcomes for government operations. While specific contractor names are not available, Diania’s contracting patterns reflect consistent engagement with a diverse pool of vendors, including manufacturers, wholesale distributors, and equipment lessors operating in regulated industries. Her working relationships emphasize vendor reliability, regulatory compliance, and technical capability, particularly among firms capable of meeting stringent quality and safety standards for medical and laboratory-grade products. She fosters collaborative partnerships with suppliers who demonstrate strong performance histories and adherence to federal contracting requirements. Diania exhibits a strong preference for open competition, with 84.6% of her acquisitions conducted without set-asides. However, she actively supports small business participation, consistently awarding contracts under Total Small Business Set-Asides (FAR 19.5) and Service-Disabled Veteran-Owned Small Business (SDVOSB) set-asides, each accounting for 7.7% of her portfolio. This balanced approach reflects a commitment to socioeconomic goals while maintaining competitive integrity and mission readiness. Her primary procurement focus lies in NAICS 424210 (Drugs and Druggists’ Sundries Merchant Wholesalers), 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing), and 334516 (Analytical Laboratory Instrument Manufacturing), indicating specialized expertise in pharmaceutical distribution, diagnostic and therapeutic medical equipment, and precision laboratory instrumentation. She routinely procures high-complexity goods requiring regulatory validation, demonstrating a nuanced understanding of FDA-regulated supply chains and technical specifications critical to public health and scientific research.